MHNPC

Clinical trials for MHNPC explained in plain language.

Never miss a new study

Get alerted when new MHNPC trials appear

Sign up with your email to follow new studies for MHNPC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug combo tested to control advanced prostate cancer

Disease control Not yet recruiting

This early-stage study is testing whether adding an experimental oral drug called LC-K76 to standard hormone therapy helps control metastatic prostate cancer that still responds to hormones. It will involve about 40 men who have not had prior cancer treatment, focusing primarily …

Matched conditions: MHNPC

Phase: EARLY_PHASE1 • Sponsor: Shanghai Changzheng Hospital • Aim: Disease control

Last updated Mar 24, 2026 12:03 UTC

MHNPC

Get alerted when new MHNPC trials appear

New drug combo tested to control advanced prostate cancer